P129 What is the patient’s preference: tiotropium monotherapy or fixed-dose indacaterol/glycopyrronium combination therapy? - the FAVOUR study | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Poster sessions

Phenotypes and response to treatment in COPD

P129 What is the patient’s preference: tiotropium monotherapy or fixed-dose indacaterol/glycopyrronium combination therapy? - the FAVOUR study

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Kardos P, Hagedorn I

P129 What is the patient’s preference: tiotropium monotherapy or fixed-dose indacaterol/glycopyrronium combination therapy? - the FAVOUR study

Thorax 2015;70:A141.